United States Anticoagulation Therapy Market Analysis - Global Industry Size, Share, Trends and Forecast, 2018 – 2026

Category : Healthcare and Pharmaceuticals | Delivery Format : PDF | Status: Forthcoming | Report ID : ARC790


Anticoagulants also known as blood thinner are chemical compounds that reduce or prevent coagulation of blood, persisting the coagulation time. Anticoagulants treatment can also take place through natural medium from blood-eating animals such as vampire finches, leeches and mosquitoes, as they help in keeping the bite area unclotted for long time. As a class of medications in thrombotic disorders anticoagulants are also used in therapy. Oral anticoagulants (OACs) are also taken by several people in form of pills or tablets, and various arterial anticoagulant dosage forms are used by clinics and hospitals. Some anticoagulants are used in therapeutic equipment, such as dialysis equipment, serum-separating tubes, test tubes and blood transfusion bags.

Market Dynamics

Growing incidence of arrhythmia, blood vessel thromboembolism, and stroke, rising mandate for Noacs as substitutes to anticoagulant are some of the factors driving the growth of this market. However, high development expenses are hampering the growth of this market. Increasing range of patients demanding life-long medical aid therapy are expected to boost the growth of this market during forecast period.

Market Classification

The market can be bifurcated on the basis of therapy products, and clinics. By therapy products, Unites States anticoagulation therapy market can be segmented into drugs and PT/INR Testing Devices. By drugs market is segmented into novel oral anticoagulants (NOACs), warfarin, and among others. Also, PT/INR testing devices are further segmented into in-office testing devices, analyzers, reagents and kits, home testing devices. By clinics, Unites States anticoagulation therapy market can be segmented into service and clinic. By service market is segmented into testing services and consulting services and based on clinic market is further bifurcated into hospital associated clinic, independent clinics, pharmacy-based clinics.

Report Coverage


Unites States Anticoagulation Therapy Market

Analysis Period

2015 – 2026

Historic Data

2015 – 2016

Base Year


Forecast Data

2018 – 2026

Market Stratification

Therapy Products, Clinics

Report Coverage

Market Trends, Drivers, Restraints, Porter's Five Forces Analysis,

Competitive Analysis, Player Profiling, Value Chain Analysis


Market Participants

Some of the major players involved in Unites States anticoagulation therapy market based on therapy include C. H. Boehringer Sohn AG & Ko, Bristol-Myers Squibb, Johnson & Johnson, Pfizer Inc., Daiichi Sankyo Company Ltd., and Portola Pharmaceuticals among others.

Market Segmentation

Market ByTherapy Products

  • By Drugs
    • Novel Oral Anticoagulants (NOACs)
    • Warfarin
    • Other Drugs
  • By PT/INR Testing Devices
    • In-Office Testing Devices
    • Analyzers
    • Reagents and Kits
    • Home Testing Devices

Market By Clinics

  • By Service
    • Testing Services
    • Consulting Services
  • By Clinic
    • Hospital Associated Clinic
    • Independent Clinics
    • Pharmacy-based Clinics


Cart Summary